New RRx-001 Non-Randomized Trial (Northern CA & NJ)

Please feel free to read, share your thoughts, your stories and connect with others!
User avatar
Posts: 510
Joined: Tue Sep 17, 2013 8:31 am
Location: San Diego

New RRx-001 Non-Randomized Trial (Northern CA & NJ)

Postby DK37 » Wed Jun 15, 2016 2:38 pm

A new RRx-001 clinical trial is about to start (use the search box for my previous posts on it). Briefly: this is the drug which 1.) in preliminary data appears to sensitize multiple patients to previously failed irinotecan 2.) has very few side effects seen thus far. It's largest current trial is a randomized trial against Stivarga where RRx-001 is dosed sequentially: first RRx-001, then irinotecan. Just for the few people that don't know, irinotecan is the key component to FOLFIRI.

A new trial is about to start which does the next logical step - ask the question: if you dose RRx-001 simultaneously with irinotecan do you prevent/delay the emergence of resistance and gain a significant amount of time before progression?? Unlike the current Phase 2 trial for CRC, this trial is not being randomized so you're not being chanced with ending up with Stivarga...

The inclusion criteria are quite lenient. Brain mets allowed. You can either have had "or declined" standard of care chemo.

It is in two locations Northern California (Davis) and the east coast (NJ). ... 097&rank=1

6/4/2012 Dx Stage 3C CRC @ 40 yo. MSS, KRAS-WT, BRAF-WT, p53-mut
2/13 NED!
8/13 Enlarged lymphs - Stable
10/14 Stage IV. Lung & Lymph mets. 5-FU+bev
3/15 Cetuximab
11/15 FOLFIRI + bev
11/16 Signs of FOLFIRI resistance (Lymph mets)
1/17 Palliative radiation for resistant mets
2/17 FOLFIRI + bev + Maraviroc (off-label)
3/17 FOLFIRI + Erbitux + Maraviroc (off-label)
MSS-CRC Clinical Trial Finder:
2016 Colondar 2.0 Model
DK37 Science Posts List

Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”

Who is online

Users browsing this forum: tminor5 and 46 guests